Rybelsus 7 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0CA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,569
Award facts
- Contract value 100% obligated
- $25,568.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $25,568.65 and an ultimate completion date of December 11, 2025. The contract has no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Rybelsus tablets being delivered under this order represent a diabetes medication component of the company's extensive federal contract awards with DLA, which demonstrate its capability to meet federal procurement requirements through open competition and deliver pharmaceutical products at scale to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FR0CA?
SPE2DR26FR0CA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FR0CA worth?
The government has obligated $25,569 on SPE2DR26FR0CA.
Is contract SPE2DR26FR0CA an order under another contract?
Yes. SPE2DR26FR0CA is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0CA competed?
The extent of competition for SPE2DR26FR0CA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award